Trial Profile
A Phase III,Randomized,Open Label Study Comparing Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa up to 2-3 Years for less than 45 Year Old Pre-menopausal Hormone Receptor-positive Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary) ; Anthracyclines; Tamoxifen; Taxanes
- Indications Breast cancer
- Focus Therapeutic Use
- 24 Aug 2017 Status changed from recruiting to completed.
- 01 Dec 2012 New trial record